BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1015680)

  • 41. Transfer factor and its clinical application.
    Schulkind ML; Ayoub EM
    Adv Pediatr; 1980; 27():89-115. PubMed ID: 7013447
    [No Abstract]   [Full Text] [Related]  

  • 42. First experience with immunomodulation in septic shock.
    Josten C; Muhr G; Sistermann R
    Prog Clin Biol Res; 1989; 308():989-94. PubMed ID: 2528747
    [No Abstract]   [Full Text] [Related]  

  • 43. High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapy.
    Kushner BH; Cheung IY; Kramer K; Modak S; Cheung NK
    Pediatr Blood Cancer; 2007 Apr; 48(4):430-4. PubMed ID: 16421906
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic mucocutaneous candidiasis.
    J Cutan Pathol; 1974; 1(5):211-29. PubMed ID: 4470726
    [No Abstract]   [Full Text] [Related]  

  • 45. [Primary and secondary neuroblastoma in E.N.T. region (author's transl)].
    Jung H; Gutjahr P
    Laryngol Rhinol Otol (Stuttg); 1974 Jul; 53(7):500-10. PubMed ID: 4410502
    [No Abstract]   [Full Text] [Related]  

  • 46. Orally administered specific transfer factor for the treatment of herpes infections.
    Viza D; Vich JM; Phillips J; Rosenfeld F
    Lymphokine Res; 1985; 4(1):27-30. PubMed ID: 4039018
    [No Abstract]   [Full Text] [Related]  

  • 47. [Principles and results of treatment of infantile carcinosis represented by osteogenic sarcoma, Wilms' tumor and neuroblastoma (author's transl)].
    Hecker WC; Schiersmann S
    MMW Munch Med Wochenschr; 1974 May; 116(22):1143-52. PubMed ID: 4368226
    [No Abstract]   [Full Text] [Related]  

  • 48. Transfer factor II: results of therapy.
    Spitler LE; Levin AS; Fudenberg HH
    Birth Defects Orig Artic Ser; 1975; 11(1):449-56. PubMed ID: 1096990
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cellular immunity in acne vulgaris during transfer factor treatment.
    Ashorn R; Uotila A; Kuokkanen K; Räsänen L; Karhumäki E; Krohn K
    Ann Clin Res; 1985; 17(4):152-5. PubMed ID: 2934019
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumor-directed immunity in human neuroblastoma.
    Morrison LJ; Cochran AJ; Baird GM; Campbell AM; Willoughby ML
    Am J Pediatr Hematol Oncol; 1982; 4(1):3-9. PubMed ID: 7046494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cell-mediated immune reactions to clinical neuroblastoma.
    Okabe I; Kurosu Y; Morita K
    Jpn J Surg; 1985 Sep; 15(5):368-74. PubMed ID: 3878429
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Treatment of candidasis granuloma with "transfer factor"].
    Escudero Gil R; Simón Merchan A; Pino del Corral E; Moreno Izquierdo R
    Actas Dermosifiliogr; 1976; 67(7-8):589-98. PubMed ID: 961527
    [No Abstract]   [Full Text] [Related]  

  • 53. Results of a Phase I study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children with Stage 4 neuroblastoma.
    Caruso DA; Orme LM; Amor GM; Neale AM; Radcliff FJ; Downie P; Tang ML; Ashley DM
    Cancer; 2005 Mar; 103(6):1280-91. PubMed ID: 15693021
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Cellular immune defect and transfer factor therapy in epidermolysis bullosa simplex of the Weber-Cockayne type].
    Göring HD; Ott D; Schwalm I; Ziemer A
    Dermatol Monatsschr; 1988; 174(1):10-3. PubMed ID: 3356286
    [No Abstract]   [Full Text] [Related]  

  • 55. [Malignant tumours in childhood (author's transl)].
    Dtsch Med Wochenschr; 1973 Nov; 98(48):2267-74. PubMed ID: 4357728
    [No Abstract]   [Full Text] [Related]  

  • 56. [Transfer factor immunotherapy as an adjunct to surgery in lung cancer].
    Fujisawa T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Jan; 23(1):68-73. PubMed ID: 3892117
    [No Abstract]   [Full Text] [Related]  

  • 57. Disialoganglioside directed immunotherapy of neuroblastoma.
    Modak S; Cheung NK
    Cancer Invest; 2007 Feb; 25(1):67-77. PubMed ID: 17364560
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunotherapy of neuroblastoma: present, past and future.
    Raffaghello L; Pistoia V
    Expert Rev Neurother; 2006 Apr; 6(4):509-18. PubMed ID: 16623650
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical results of transfer factor (BBZ Plauen) therapy in immunodeficient children.
    Wiersbitzky S; Bruns R; Laube F; Reddemann H
    Padiatr Grenzgeb; 1987; 26(6):439-41. PubMed ID: 3502020
    [No Abstract]   [Full Text] [Related]  

  • 60. [The effect of the transfer factor on T lymphocytes in children with recurrent otitis media].
    Kamínková J; Kaspárek L; Vránová M; Pekárek J; Svandová E
    Cas Lek Cesk; 1983 Jun; 122(25):779-82. PubMed ID: 6603269
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.